Feedback / Questions
vilastobart (XTX101) - Xilio Therap
https://www.globenewswire.com/news-release/2025/05/31/3091401/0/en/Xilio-Therapeutics-Announces-Updated-Phase-2-Data-for-Vilastobart-a-Tumor-Activated-Anti-CTLA-4-in-Combination-with-Atezolizumab-in-Patients-with-Metastatic-Microsatellite-Stable-C.html
May 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next